CD19-directed chimeric antigen receptor T-cell therapy: what can we learn from the haematologist? by Marie José Kersten, Maria Theresa Kuipers

Get full text

Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment by Karima Amaador, Pythia T. Nieuwkerk, Monique C. Minnema, Marie José Kersten, Josephine M. I. Vos

Get full text

Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem by Esther Lutgens, Marie José Kersten, Tom T.P. Seijkens, Kikkie Poels, Suzanne I.M. Neppelenbroek, M. Louisa Antoni

Get full text

Enteropathy‐associated T‐cell lymphoma: A population‐based cohort study on incidence, treatment, and outcome in the Netherlands by Frederik O. Meeuwes, Mirian Brink, Wouter J. Plattel, Joost S. P. Vermaat, Marie José Kersten, Mariëlle Wondergem, Otto Visser, Marjolein W. M. van derPoel, Rimke Oostvogels, F. J. Sherida H. Woei‐A‐Jin, Lara Böhmer, Tjeerd J. F. Snijders, Gerwin A. Huls, Marcel Nijland

Get full text

Monitoring multidimensional aspects of quality of life after cancer immunotherapy: protocol for the international multicentre, observational QUALITOP cohort study by Geertruida H De Bock, Delphine Maucort-Boulch, Clémence Leyrat, Amélie Anota, Stephane Dalle, Susana Puig, Marie Préau, Mohammad S Jalali, Marie-Jose Kersten, Martijn GH van Oijen, Mathieu Fauvernier, Petra C. Vinke, Marc Combalia, Anne Mea Spanjaart, Maria Gomes da Silva, Aurore Fouda Essongue, Aurélie Rabier, Myriam Pannard, Amal Elgammal, Mike Papazoglou, Mohand-Said Hacid, Catherine Rioufol, Erick Suazo-Zepeda, Ananya Malhotra, Emmanuel Coquery, Elsa Coz

Get full text